Aromatic Sulfonamides including a Sulfonic Acid Tail: New Membrane Impermeant Carbonic Anhydrase Inhibitors for Targeting Selectively the Cancer-Associated Isoforms
Open Access
- 31 December 2021
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 23 (1) , 461
Abstract
We report here a new drug design strategy for producing membrane-impermeant carbonic anhydrase (CA; EC 4.2.1.1) inhibitors selectively targeting the tumor-associated, membrane-bound human CAs IX and XII over off-target cytosolic isoforms. To date, this approach has only been pursued by including permanent positively charged pyridinium type or highly hydrophilic glycosidic moieties into the structure of aromatic sulfonamide CA inhibitors (CAIs). Aliphatic (propyl and butyl) sulfonic acid tails, deprotonated at physiological pH, were thus incorporated onto a benzenesulfonamide scaffold by a common 1,2,3-triazole linker and different types of spacers. Twenty such derivatives were synthesized and tested for their inhibition of target (hCAs IV, IX, and XII) and off-target CAs (hCAs I and II). Most sulfonate CAIs induced a potent inhibition of hCAs II, IX, and XII up to a low nanomolar KI range (0.9–459.4 nM) with a limited target/off-target CA selectivity of action. According to the drug design schedule, a subset of representative derivatives was assessed for their cell membrane permeability using Caco-2 cells and a developed FIA-MS/MS method. The complete membrane impermeability of the sulfonate tailed CAIs (≥98%) validated these negatively charged moieties as being suitable for achieving, in vivo, the selective targeting of the tumor-associated CAs over off-target ones.Keywords
Funding Information
- Ministero dell’Istruzione, dell’Università e della Ricerca (PRIN: prot. 2017XYBP2R)
This publication has 59 references indexed in Scilit:
- Structure-based drug discovery of carbonic anhydrase inhibitorsJournal of Enzyme Inhibition and Medicinal Chemistry, 2012
- Mechanisms of Hedgehog pathway activation in cancer and implications for therapyTrends in Pharmacological Sciences, 2009
- Hypoxia-Inducible Carbonic Anhydrase IX and XII Promote Tumor Cell Growth by Counteracting Acidosis through the Regulation of the Intracellular pHCancer Research, 2008
- Hedgehog: functions and mechanismsGenes & Development, 2008
- Carbonic anhydrases: novel therapeutic applications for inhibitors and activatorsNature Reviews Drug Discovery, 2008
- Targeting tumor-associated carbonic anhydrase IX in cancer therapyTrends in Pharmacological Sciences, 2006
- A Novel Class of Carbonic Anhydrase Inhibitors: Glycoconjugate Benzene Sulfonamides Prepared by “Click-Tailing”Journal of Medicinal Chemistry, 2006
- Hypoxia activates the capacity of tumor‐associated carbonic anhydrase IX to acidify extracellular pHFEBS Letters, 2004
- Carbonic Anhydrase Inhibitors. Design of Selective, Membrane-Impermeant Inhibitors Targeting the Human Tumor-Associated Isozyme IXJournal of Medicinal Chemistry, 2004
- Carbonic anhydrase IX reduces E-cadherin-mediated adhesion of MDCK cells via interaction with β-cateninExperimental Cell Research, 2003